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The Ruanjian Sanjie Decoction (RSD) is a traditional Chinese medicine (TCM) formulation consisting 
of Spica Prunellae, Pseudobulbus Cremastrae Seu Pleiones, Concha Ostreae and Semen Coicis, and 
widely used as an adjuvant in anti-cancer therapy. The aim of this study was to determine the effects of 
RSD on the extracellular matrix (ECM) of tumors, and on the efficacy of anti-cancer nano-formulations 
in a tumor-bearing mouse model. The mice were treated with triptolide encapsulated in PEG-modified 
liposomes (TP-PEG-LPs), either alone or in combination with RSD. The combination treatment 
significantly retarded tumor growth relative to the untreated controls, indicating the potent adjuvant effect 
of RSD in targeted anti-cancer therapy. In addition, RSD also reduced the amount of total collagen and 
collagen I and increased that of collagen III in the tumor ECM, along with decreasing the expression 
of the pro-angiogenic VEGF. Finally, even high doses of RSD did not significantly affect the liver and 
kidney function or body weight, indicating low toxicity.
Keyword: Traditional Chinese medicine. Ruanjian Sanjie Decoction.  Tumor matrix. Anti-tumor efficacy. 
Nano-formulations.
INTRODUCTION
Nano-formulations are a new generation of anti-
tumor therapeutics, and include liposome-encapsulated 
drugs (e.g. Doxil/Caelyx and DaunoXome which are 
liposomal preparations of doxorubicin and daunorubicin 
respectively) and nanoparticles (e.g. the paclitaxel albumin 
nanoparticle preparation Abraxane) (Cortes et al., 2015; 
Gradishar et al., 2005; O’Brien et al., 2004). These 
drug-loaded nanosystems accumulate in the perivascular 
regions of the tumor owing to their size and the abnormal 
tumor vasculature, a phenomenon known as enhanced 
permeability and retention or EPR (O’Brien et al., 2004; 
Matsumura et al., 1986). However, their therapeutic effects 
have been largely ineffective in fibrotic tumors like breast 
and colon cancers, since the small inter-fibrillar spacing in 
the tumor interstitium restricts the permeability of nano-
formulations larger than 10 nm (Mujtaba et al., 2013; 
Netti et al., 2000). In addition, abnormal extracellular 
matrix (ECM) formation also limits the entry of nano-
formulations into the deeper parts of the tumor through the 
vasculature. Matrix solubilizers such as relaxin, bacterial 
collagenase and angiotensin-converting enzyme (ACE) 
inhibitors have been used to break the collagen network 
in tumors, but are associated with potential adverse 
effects like increased risk of tumor progression (relaxin), 
hypotension (ACE inhibitors) or systemic toxicity (bacterial 
collagenase) (Netti et al., 2000; Diop-Frimpong et al., 2011; 
McKee et al., 2006; Kim et al., 2006).
Ruanjian Sanjie Decoction (RSD) is a traditional 
Chinese medicine (TCM) formulation consisting of Spica 
Prunellae, Pseudobulbus Cremastrae Seu Pleiones, Concha 
Ostreae and Semen Coicis, and has been traditionally used 
to treat turbid phlegm caused by blood stagnation. It is 
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also used as an adjuvant in anti-tumor therapy, on account 
of its ability to “soften” and then gradually “dissipate” 
the tumors as per TCM principles (Li et al., 2015). Intra-
gastric gavage of RSD in tumor bearing rats enhanced 
5-FU absorption in the tumors, while inhibiting its spread 
to healthy tissues, indicating that dissolution of the tumor 
collagen network is the likely mechanism underlying RSD 
action (Huang, Huang, Zheng, 2010). We hypothesized 
therefore that combining RSD with anti-cancer nano-
formulations can augment the therapeutic efficacy of the 
latter. Accordingly, we tested the ability of RSD to weaken 
the tumor ECM barrier and increase the therapeutic effects 
of triptolide encapsulated in PEG-modified liposomes 
(TP-PEG-LPs) in a tumor-bearing mouse model.
MATERIAL AND METHODS
Material 
Spica Prunellae (Prunella vulgaris L), Pseudobulbus 
Cremastrae Seu Pleiones (Pleione bulbocodioides Rolfe), 
Concha Ostreae (Ostrea gigas Thunberg) and Semen 
Coicis (Coix lacryma-jobi L) were purchased from 
Zhejiang Chinese Medicine University Chinese medicine 
Pieces Factory. Soy bean phosphatidylcholine (SPC) was 
bought from Lipoid GmbH (Ludwigshafen, Germany), 
cholesterol from Sigma-Aldrich (USA), mPEG2000-DSPE 
from Fangshuo Co. Ltd. (Shanghai, China), and triptolide 
from Huawei Rui Ke Chemical Co. Ltd. (Beijing, China). 
The remaining reagents were bought from Huadong 
Pharmaceutical Co. Ltd. (Hangzhou, China).
Cell lines and animals
The NIH-3T3 and MDA-MB-231 breast cancer cell 
lines were provided by the Type Culture Collection of the 
Chinese Academy of Sciences (Shanghai, China). Eight-
weeks old female SPF-grade BALB/c nude mice weighing 
~20 g were purchased from Zhejiang University Animal 
Laboratory. The animals were acclimatized for 7 days in 
an environmentally controlled room with temperature 
20~26 °C and relative humidity 40%~70% under a 
12 h light/dark cycle. Food and water were provided ad 
libitum. All procedures related to animal handling and 
care were conducted in accordance to the institutional and 
governmental protocols.
Preparation of TP-PEG-LPs and RSD 
TP-PEG-LPs were prepared using the thin-film 
hydration method as described previously (Cai et al., 
2015). Briefly, triptolide, cholesterol, lecithin and DSPE-
PEG2000 were dissolved in 10 mL chloroform in a 500 
mL round bottomed flask, and evaporated in a water bath 
at 40 °C for 40 min with constant rotation (90 rpm) to 
remove the chloroform. The resulting solution was then 
vacuumed for 60 min till a uniform lipid film was formed 
on the flask wall. The flask was rinsed with PBS, and 
warmed in a water bath at 40 °C for 40 min (with constant 
rotation at 90 rpm). The liposome solution was stirred in 
a magnetic field for 30 min at 1000 rpm, and sonicated in 
an ice bath (1s pulses separated by 1s intervals) to isolate 
the liposomes.
The RSD formulation was prepared by mixing Spica 
Prunellae, Pseudobulbus Cremastrae Seu Pleiones, Concha 
Ostreae and Semen Coicis in the ratio of 10:15:10:30 by 
weight, in 8 times the volume of cold water. The mixture 
was soaked for 5 hours, boiled for 30 min and filtered, and 
the remaining dregs were extracted again with 6 times the 
amount of water, followed by another round of boiling and 
filtering. Both filtrates were combined, and condensed to 
a suitable concentration, measured as the total decoction 
mass/final solution volume, in a rotary evaporator. Low-
dose, medium-dose and high-dose RSD formulations were 
prepared by diluting the concentrated mix to 0.75 g/mL, 
1.5 g/mL and 3 g/mL respectively. 
Establishment of tumor model and treatment 
regimen
The MDA-MB-231 and NIH3T3 lines were cultured 
at 37 °C under 5% CO2, harvested, and combined in the ratio 
of 1:2 to the final density of 7.5*106/mL (2.5*106 NIH3T3 
and 5*106  MDA-MB-231 cells). The nude mice were each 
subcutaneously injected with 1x107 cells in their left hind 
limbs, and once the tumor volumes reached 60-100 mm3, 
were randomized into the following groups (n = 6 each) 
based on the 17-day treatment regimens: 1) control group 
received intra-gastric gavage of physiological saline for the 
entire duration, 2) TP-PEG-LP group received saline gavage 
for the first 7 days, followed by daily intravenous injections 
of 0.05 mg/kg TP-PEG-LPs for 10 days, and the 3) low-dose 
RSD + TP-PEG-LPs, 4) medium dose RSD + TP-PEG-LPs 
and 5) high-dose RSD + TP-PEG-LPs groups were given 
daily intra-gastric gavages of 0.75 g/100g, 1.5 g/100g and 
3 g/100g RSD respectively for the first 7 days, followed by 
0.05 mg/kg TP-PEG-LPs and (same dose) RSD decoction 
daily for 10 days.  
The body weight of the mice and tumor size were 
measured on alternate days. On day 18 of the regimen, the 
mice were sacrificed and the tumors were dissected. The 
tumor tissues were weighed and measured, and the tumor 
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volume (V) was calculated as V (cm3) = 1/2ab2, where 
a is the longest diameter and b is the shortest diameter. 
The relative tumor volume (RTV) was calculated as 
Vt/V0, where V0 is the pre-treatment tumor volume and 
Vt is the tumor volume measured after each drug dosage. 
The relative tumor proliferation rate (T/C) was calculated 
as RTVt/RTVc×100% where RTVt is the average RTVof 
the drug-administered group and RTVc is the mean RTV 
of the model control group. The percentage of tumor 
weight inhibition (TWI%) was determined according to 
the following formula: 
According the “Guidelines for Non-Clinical 
Research Techniques of Cytotoxic Antitumor Drugs” by 
the SFDA, the drug efficacy was evaluated as ineffective 
when T/C value was >40%, and effective when T/C was 
≤ 40% with Vt or RTV significantly lower compared to 
that of the control group (p<0.05), or when TWI% was 
≥ 40% and the difference between the tumor weights of 
the treatment and control groups was significant compared 
to that of the control group (P < 0.05).
Immunohistochemistry 
Tumor tissues were fixed in 10% buffered formalin 
and embedded in paraffin. The 15µm-thick tissue sections 
were dewaxed with xylene, dehydrated though an ethanol 
gradient, and stained with anti-VEGF, anti-collagen type I 
and anti-collagen type III antibodies according to standard 
protocols. The staining intensity or cumulative optical 
density (IOD) of each sample was evaluated using the 
Image-Pro Plus 6.0 software, and the percentage IOD 
relative to tissue area (IOD/Area*100%) was calculated.
Measurement of total collagen content 
The tumor tissues were processed as described 
above, and the sections were stained with 0.1% solid green 
and 0.1% Sirius red in a saturated aqueous picric acid 
solution at room temperature for 30 mins. The slides were 
washed repeatedly with distilled water until the excess 
dyes were completely removed. The stained sections 
were then scraped off from the slides with a knife, and 
each sample was dissolved in 150 μL of 0.05 M aqueous 
NaOH and 50% methanol solution with gentle shaking. 
The absorbance (OD) of the eluents were measured at 
540 nm (Sirius red) and 605 nm (solid green) after M5 
enzyme labeling, and the collagen content was calculated 
as follows:
Non-collagen protein (mg) = OD605nm / 2.08
Collagen (µg)= [OD540nm - 0.26 × OD605nm] / 38.4
Total collagen content (µg/mg protein) = collagen (µg) / 
collagen (µg) + non-collagen protein (mg)
Scanning electron microscopy (SEM) of tumor 
ECM
The tumor tissues were fixed with 1% citric acid in 
0.1 mM phosphate buffer for 2 hours, rinsed again with the 
buffer, and then dehydrated through an ethanol gradient. 
After drying to a critical point, the tissue surfaces were 
vacuum coated with platinum for 10 min using a coating 
instrument. The ultrastructure of the tumor matrix and 
stroma were observed using the SEM.
Toxicity evaluation
To evaluate drug toxicity, the main indicators of liver 
and renal functions were measured at the end of the dosing 
cycle, and the body weight of the mice was regularly 
monitored during the entire treatment period.
Statistical analysis 
SPSS 22.0 program was used for all statistical 
analysis. After assessing the normality of distribution, 
the data were suitably analyzed using the non-parametric 
Mann-Whitney test or Student’s t test. A P value <0.05 was 
considered statistically significant.
RESULTS
RSD enhances the anti-tumor effects of 
TP-PEG-LPs
Compared to the untreated control group, the tumor-
bearing mice in all treatment groups showed significantly 
less tumor growth in terms of both weight and volume 
(p<0.05 or P<0.01). Furthermore, inclusion of RSD further 
augmented the tumor inhibitory effects of TP-PEG-LPs in 
a dose-dependent manner (P<0.05 or P<0.01) (Figure 1 
and Table I). In addition, combination of all doses of RSD 
with TP-PEG-LPs achieved > 40% TWI, with high-dose 
RSD showing the maximum inhibitory effects. Although 
TP-PEG-LPs alone decreased the tumor volume, RTV 
and tumor weight compared to the control group, the T/C 
was > 40% and TWI < 40% after the last administration, 
indicating overall poor anti-tumor efficacy. Inclusion of 
RSD significantly improved the above parameters (P<0.05 
or P<0.01). In addition, although RSD exerted its effects 
in a dose-dependent manner, no significant differences 
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were seen between the different dose-administered groups 
(P>0.05). Taken together, RSD significantly augmented 
the anti-tumor action of TP-PEG-LPs.
RSD decreases total collagen content and 
differentially modulates collagen I and III in the 
tumor matrix
The total and relative (to the total tissue protein) 
collagen content of tumors were highest in the untreated 
controls, and both significantly decreased in the RSD-
treated groups in a dose dependent manner (Figure 2). 
In addition, RSD significantly decreased the content of 
collagen I, which is known to promote tumor proliferation 
and invasion, in a dose-dependent manner (P<0.05; 
Figure 3 and Table II). In contrast, the lowest amount of 
the anti-metastatic collagen III was seen in the untreated 
controls, which increased only slightly in the TP-PEG-LPs 
group (P>0.05) but significantly with the addition of 
RSD (P<0.05), albeit not in a dose-dependent manner 
(Figure 4).
RSD disrupts tumor matrix morphology and 
angiogenesis
SEM indicated dense collagen fibers in the untreated 
as well as the TP-PEG-LPs-treated tumors, and inclusion 
of RSD significantly disintegrated the collagen fibers 
in a dose-dependent manner (Figure 5). VEGF, a pro-
angiogenic factor that is frequently overexpressed in 
tumors and is a target of various anti-tumor drugs, was 
only slightly reduced by TP-PEG-LPs alone (P>0.05). 
However, addition of RSD led to a significant reduction 
in VEGF levels (P<0.05 or P<0.01) in a dose independent 
manner (Figure 6).
RSD does not adversely affect normal tissues
Systemic drug toxicity in the mice was evaluated 
using routine tests for liver and kidney functions, and by 
regular monitoring of body weight. The combination of 
RSD and TP-PEG-LPs did not significantly affect any of 
these indicators, even at high doses (Figure 7).
FIGURE 1 A - Tumor growth inhibition (A is the intact figure and A1 is the amplificatory figure.). B - mice were sacrificed and 
the resected tumors were photographed. C - Tumor weight at the time of sacrifice. Values are expressed as mean±SD, n=5. 
Notice:**p < 0.01 vs control group; #p < 0.05 vs TP-PEG-LPs.
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Day 3 Day 5 Day 7 Day 9 Day 11 Day 13 Day 15 Day 17
Control group 100 100 100 100 100 100 100 100 /
TP-PEG-LPs group 96.37 77.28 86.03 78.57 99.86 82.62 83.92 74.57 36.92
low-dose RSD with 
TP-PEG-LPs group
52.82 57.32 54.21 68.17 67.95 53.66 53.56 51.10 60.52
medium-dose RSD with 
TP-PEG-LPs group
59.36 51.15 51.06 55.22 59.09 56.11 52.07 49.01 59.82
high-dose RSD with 
TP-PEG-LPs group
47.66 38.52 35.96 39.20 49.59 43.60 44.96 45.55 69.19
FIGURE 2 - RSD with TP-PEG-LPs differentially modulates 
total collagen in the tumor matrix.Values are expressed as 
mean±SD, n=5. Notice:**p < 0.01 vs control group; #p < 0.05 
vs TP-PEG-LPs.
FIGURE 3 - RSD with TP-PEG-LPs differentially modulates collagen I in the tumor matrix.Tumor sections from each group of 
animals were immunostained for collagen I.The photographs are representative of sections from 5 tumors/group(×200).(A):Control 
group; (B):TP-PEG-LPs group; (C):Low-dose RSD with TP-PEG-LPs group; (D):Medium-dose RSD with TP-PEG-LPs group; 
(E)High-dose RSD with TP-PEG-LPs group. Notice:**p < 0.01 vs control group; #p < 0.05 vs TP-PEG-LPs.
DISCUSSION
Nano-formulations of chemotherapeutic drugs 
have been in clinical practice for almost two decades, but 
despite improved tumor targeting and reduced toxicity, 
have largely shown poor anti-tumor efficacy. In addition 
to the intrinsic physical and chemical properties of the 
nano-formulations, several features of the tumor micro-
environment like abnormal vasculature, dense ECM, low 
pH, hypoxia and high interstitial pressure considerably 
limit the therapeutic efficacy of nano-formulations (Dolor, 
Szoka, 2018; Glicksman et al., 2017; Goel et al., 2011).
Cancer associated fibroblasts (CAFs) can induce 
interstitial fibrogenesis, accumulation and cross-linking of 
ECM proteins, and fibrous bundle formation, all of which 
harden the tumor texture (Egeblad, Nakasone, Werb, 
2010). Myofibroblasts are abundant in breast cancer, and 
their contraction shrinks and hardens the adjacent tissues 
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(Liu et al., 2016). In addition, CAFs can also promote 
tumor angiogenesis and provide nutritional support for 
the tumor cells (Eiro et al., 2018). Therefore, CAFs are 
an attractive therapeutic target against cancer. Recently, 
we found that TP-PEG-LPs alone could not significantly 
inhibit tumor growth, likely due to size restriction and 
nano-surface modifications. However, their therapeutic 
effects increased significantly by combining them with 
RSD, a TCM formulation frequently used to reduce 
phlegm, soften tumor hardness, increase circulation 
and remove blood stasis, and strengthen the spleen and 
stomach. In addition, RSD is also used as an adjuvant in 
the treatment of various cancers. 
TCM formulations like RSD have multiple targets 
and mechanisms of action, and their therapeutic effects 
depend on the proportion of individual constituents. 
Spica Prunellae is the main ingredient of RSD, and 
TABLE II - Immunohistochemical assay for the collagen I area.Values are expressed as Median(Max,Min), n=5




Low-dose RSD with TP-PEG-LPs group 4.60(11.25,1.78)
Medium-dose RSD with TP-PEG-LPs group 4.51(9.44,0.76)
High-dose RSD with TP-PEG-LPs group 3.70(7.80,0.12)
FIGURE 4 - RSD with TP-PEG-LPs differentially modulates 
collagen III in the tumor matrix.Tumor sections from each 
group of animals were immunostained for collagen III.The 
photographs are representative of sections from 5 tumors/
group(×200).(A):Control group; (B):TP-PEG-LPs group; 
(C):Low-dose RSD with TP-PEG-LPs group; (D):Medium-
dose RSD with TP-PEG-LPs group; (E)High-dose RSD with 
TP-PEG-LPs group.Values are expressed as mean±SD, n=5.
(F)Immunohistochemical assay for the collagen III area.Values 
are expressed as mean±SD, n=5. Notice:**p < 0.01 vs control 
group; #p < 0.05 vs TP-PEG-LPs.
F IGURE 5 -  Scanning electron microscopy (SEM). 
Representative scanning electron micrographs of collagen 
fibers of the tumor matrix.The magnification shown is 10000×.
(A):Control group; (B):TP-PEG-LPs group; (C):low-dose RSD 
with TP-PEG-LPs group; (D):medium-dose RSD with TP-PEG-
LPs group; (E)high-dose RSD with TP-PEG-LPs group.
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accounts for the softening and dispersing effects. Recent 
studies show that Spica Prunellae contains sulfated 
polysaccharides and triterpenoids, which can reduce the 
content of hyaluronic acid and collagen, thereby inhibiting 
connective tissue accumulation and disintegrating 
the tumor mass (Fang et al., 2005; Itoh et al., 1993). 
Pseudobulbus Cremastrae Seu Pleiones and Semen Coicis 
are known to disperse and dissolve phlegm accumulation, 
strengthen the spleen and nourish the stomach. Concha 
Ostreae can also dissipate phlegm, and is used to treat 
phlegm fire and stagnation. 
To further explore the mechanism of the action 
of RSD, we analyzed its effects on various types of 
collagen. While RSD significantly reduced the total 
collagen content in tumor tissues, it had variable effects 
on individual collagen types. High-dose RSD combined 
with TP-PEG-LPs significantly reduced the content 
of collagen I, which provides mechanical support to 
the organs and maintains their structural integrity, thus 
ensuring normal functioning. In addition, it also promotes 
tumor cell proliferation, and inhibits the differentiation 
of macrophages into the anti-tumor M1 type in order to 
drive tumor invasion and metastasis (Petrella 2009; Li, 
Zhou, Guo,Si, 2010). In contrast, the amount of collagen 
III was lowest in the untreated tumors, and increased 
significantly following TP-PEG-LPs treatment (P<0.01), 
independent of RSD (P>0.05). Collagen III was shown 
to inhibit breast tumor metastasis by inhibiting adhesion, 
invasion and metastasis (Bagordakis et al., 2016). Both 
in vitro and in vivo experiments show that collagen III 
deficiency promotes tumor cell proliferation and decreases 
apoptosis (Brisson et al., 2015). Based on these findings, 
we can surmise that alteration in collagen I and collagen 
III levels is the likely mechanistic basis of the anti-tumor 
effects of RSD. Further studies are needed to validate this 
hypothesis.
Aberrant tumor vasculature is another important 
factor affecting the transport of nano-formulations. Both 
tumor cells and mesenchymal cells often have mutations 
in genes encoding for angiogenic factors, such as VEGF 
(Ma et al., 2011). The constitutive activation of VEGF 
results in curved and “leaky” tumor blood vessels, 
which promote extravasation of nano-formulations, a 
phenomenon known as EPR (Matsumura, Maeda, 1986). 
However, the EPR effect also leads to liquid overflow, 
resulting in increased tumor interstitial pressure and 
fluid viscosity, ultimately hindering the transport of 
nano-formulations and the treatment outcomes (Rofstad, 
Galappathi, Mathiesen, 2014). Furthermore, unrestricted 
tumor growth and abnormal ECM further compress the 
blood vessels, which can block blood flow and cause 
vascular rupture (You, Stallcup, 2017). While TP-PEG-
LPs alone had minimal effect on tumor VEGF levels 
(P>0.05), addition of RSD significantly reduced its 
expression (P<0.05), indicating that TP itself may not 
inhibit tumor angiogenesis. It remains to be elucidated 
whether RSD affects the tumor vasculature directly or 
indirectly through ECM disruption.
Relatively few studies have correlated the inhibition 
of tumor angiogenesis with poor delivery of nano-
FIGURE 6 - RSD with TP-PEG-LPs differentially modulates 
VEGF in the tumor matrix.Tumor sections from each group 
of animals were immunostained for VEGF.The photographs 
are representative of sections from 5 tumors/group(×200).
(A):Control group; (B):TP-PEG-LPs group; (C):Low-dose 
RSD with TP-PEG-LPs group; (D):Medium-dose RSD with 
TP-PEG-LPs group; (E):High-dose RSD with TP-PEG-LPs 
group.(F)Immunohistochemical assay for the VEGF area.Values 
are expressed as mean±SD, n=5. Notice:**p < 0.01 vs control 
group; #p < 0.05 vs TP-PEG-LPs.
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FIGURE 7 - Systemic drug toxicity in the BALB/C nude mice was evaluated using routine tests for liver and kidney, and by 
regular monitoring of body weight.(A-E):Liver function of the BALB/C nude mice;(F-G):Kidney function of the BALB/C nude 
mice;(H):Graph of nude mice weight change in the experimental period.Values are expressed as mean±SD, n=5. Notice:**p < 0.01 
vs control group; #p < 0.05 vs TP-PEG-LPs.
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formulations to the tumor sites. One study recommended 
“normalization of tumor blood vessels” as a means to 
reduce the EPR effect in order to optimize targeted drug 
delivery (Goel et al., 2011). However, this hypothesis 
contradicts our findings, and needs to be explored further. 
Another proposed strategy to enhance the intra-tumor 
diffusion of nano-formulations is to weaken the tumor 
ECM, but this may increase the risk of metastasis and 
recurrence. 
In conclusion, RSD significantly enhanced the anti-
tumor effects of TP-PEG-LPs in  dose-dependent manner, 
most likely by disrupting the collagen framework of tumor 
ECM and inhibiting the pro-angiogenic VEGF, without 
any systemic toxicity. RSD has been used in traditional 
Chinese medicine for nearly a thousand years and has a 
good therapeutic effect.Our findings show the potential of 
RSD as an adjuvant in anti-tumor therapy, and lay a strong 
foundation for future clinical trials.
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